1. Home
  2. COCO vs WVE Comparison

COCO vs WVE Comparison

Compare COCO & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Vita Coco Company Inc.

COCO

The Vita Coco Company Inc.

HOLD

Current Price

$53.77

Market Cap

3.0B

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$12.20

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COCO
WVE
Founded
2004
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.4B
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
COCO
WVE
Price
$53.77
$12.20
Analyst Decision
Buy
Strong Buy
Analyst Count
9
15
Target Price
$58.13
$31.47
AVG Volume (30 Days)
1.1M
2.2M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
26.60
N/A
EPS
1.19
N/A
Revenue
N/A
$3,704,000.00
Revenue This Year
$16.12
$0.34
Revenue Next Year
$11.40
$83.30
P/E Ratio
$46.02
N/A
Revenue Growth
N/A
149.43
52 Week Low
$25.79
$5.28
52 Week High
$61.39
$21.73

Technical Indicators

Market Signals
Indicator
COCO
WVE
Relative Strength Index (RSI) 46.20 43.18
Support Level $50.40 $6.61
Resistance Level $55.43 $14.50
Average True Range (ATR) 2.49 0.70
MACD -0.31 -0.14
Stochastic Oscillator 32.98 31.57

Price Performance

Historical Comparison
COCO
WVE

About COCO The Vita Coco Company Inc.

The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever & Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. The company has two segments: The Americas segment which comprises of operations in the U.S. and Canada; and The International segment that comprises of operations in Europe, the Middle East, Africa and the Asia Pacific regions. The Americas segment derives maximum revenue. Geographical presence of the company is in United States, United Kingdom and All other countries.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: